1. Home
  2. TRX vs CCCC Comparison

TRX vs CCCC Comparison

Compare TRX & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TRX Gold Corporation

TRX

TRX Gold Corporation

HOLD

Current Price

$0.80

Market Cap

403.8M

Sector

N/A

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.56

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRX
CCCC
Founded
1990
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
403.8M
404.7M
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
TRX
CCCC
Price
$0.80
$3.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$1.70
$12.20
AVG Volume (30 Days)
1.4M
3.1M
Earning Date
04-15-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
N/A
N/A
Revenue
N/A
$35,947,000.00
Revenue This Year
$84.84
N/A
Revenue Next Year
$96.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.02
52 Week Low
$0.33
$1.69
52 Week High
$2.80
$5.17

Technical Indicators

Market Signals
Indicator
TRX
CCCC
Relative Strength Index (RSI) 42.06 41.73
Support Level $0.68 $3.44
Resistance Level $0.89 $3.91
Average True Range (ATR) 0.05 0.25
MACD 0.01 -0.05
Stochastic Oscillator 39.49 14.36

Price Performance

Historical Comparison
TRX
CCCC

About TRX TRX Gold Corporation

TRX Gold Corp is engaged in the exploration, development, and production of mineral property interests in the United Republic of Tanzania, focused on development and mining operations, and on exploring and evaluating its mineral properties. The business of exploring and mining for minerals involves a high degree of risk, and the underlying value of the mineral properties depends on the existence and economic recovery of mineral resources and reserves, as well as the ability to raise long-term financing to continue development. The company is focused on the Buckreef Gold Project, which comprises five prospects: Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba, and includes three main mineralized zones: Buckreef South, Buckreef Main, and Buckreef North.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: